Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Translating Data From an Electronic Prescribing and Medicines Administration System into Knowledge: Application to Doctor-Nurse Time Discrepancy in Antibiotic Ordering and Administration.

Van Wilder A, Spriet I, Van Eldere J, Peetermans WE, Vanhaecht K, Vandersmissen J, Artois M, Gilis K, Vanautgaerden P, Balcaen K, Rademakers FE, Bruyneel L.

Med Care. 2019 Oct 3. doi: 10.1097/MLR.0000000000001222. [Epub ahead of print]

PMID:
31584461
2.

Bacteriophage Application for Difficult-to-treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol.

Onsea J, Soentjens P, Djebara S, Merabishvili M, Depypere M, Spriet I, De Munter P, Debaveye Y, Nijs S, Vanderschot P, Wagemans J, Pirnay JP, Lavigne R, Metsemakers WJ.

Viruses. 2019 Sep 23;11(10). pii: E891. doi: 10.3390/v11100891.

3.

Antifungal drugs: What brings the future?

Van Daele R, Spriet I, Wauters J, Maertens J, Mercier T, Van Hecke S, Brüggemann R.

Med Mycol. 2019 Jun 1;57(Supplement_3):S328-S343. doi: 10.1093/mmy/myz012.

PMID:
31292663
4.

Physician's feedback on a clinical pharmacy program on geriatric wards.

Hias J, Walgraeve K, Tournoy J, Flamaing J, Spriet I, Van der Linden L.

Acta Clin Belg. 2019 Jun 10:1-8. doi: 10.1080/17843286.2019.1629054. [Epub ahead of print]

PMID:
31179904
5.

External validation of a clinical pharmacy intervention in geriatric inpatients: a controlled study.

Van der Linden L, Decoutere L, Beerten L, Delva T, Spriet I, Flamaing J, Tournoy J.

Int J Clin Pharm. 2019 Aug;41(4):853-858. doi: 10.1007/s11096-019-00846-y. Epub 2019 May 15.

PMID:
31093941
6.

Preoperative joint aspiration culture results and causative pathogens in total hip and knee prosthesis infections: mind the gap.

Declercq P, Neyt J, Depypere M, Goris S, Van Wijngaerden E, Verhaegen J, Wauters J, Spriet I.

Acta Clin Belg. 2019 May 5:1-9. doi: 10.1080/17843286.2019.1611718. [Epub ahead of print]

PMID:
31057053
7.

Systemic antifungal drug use in Belgium-One of the biggest antifungal consumers in Europe.

Goemaere B, Lagrou K, Spriet I, Hendrickx M, Vandael E, Becker P, Catry B.

Mycoses. 2019 Jun;62(6):542-550. doi: 10.1111/myc.12912. Epub 2019 Apr 7.

PMID:
30887582
8.

Impact of an oral nutrition protocol in patients treated with elective radical cystectomy: a long term follow-up.

Declercq P, Van der Aa F, De Pourcq L, Spriet I.

Int J Clin Pharm. 2019 Apr;41(2):408-413. doi: 10.1007/s11096-019-00800-y. Epub 2019 Mar 12.

PMID:
30864080
9.

Development and implementation of "Check of Medication Appropriateness" (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance.

Quintens C, De Rijdt T, Van Nieuwenhuyse T, Simoens S, Peetermans WE, Van den Bosch B, Casteels M, Spriet I.

BMC Med Inform Decis Mak. 2019 Feb 11;19(1):29. doi: 10.1186/s12911-019-0748-5.

10.

Medication review in older adults: Importance of time to benefit.

Van der Linden L, Hias J, Spriet I, Walgraeve K, Flamaing J, Tournoy J.

Am J Health Syst Pharm. 2019 Feb 1;76(4):247-250. doi: 10.1093/ajhp/zxy038. Review. No abstract available.

PMID:
30689729
11.

Compliance with evidence-based guidelines for the prevention of central line-associated bloodstream infections in a Belgian home care setting: An observational study.

Steffens E, Spriet I, Van Eldere J, Schuermans A.

Am J Infect Control. 2019 Jun;47(6):723-725. doi: 10.1016/j.ajic.2018.10.019. Epub 2018 Dec 6.

PMID:
30527768
12.

Pharmacokinetic drug evaluation of letermovir prophylaxis for cytomegalovirus in hematopoietic stem cell transplantation.

Deleenheer B, Spriet I, Maertens J.

Expert Opin Drug Metab Toxicol. 2018 Dec;14(12):1197-1207. doi: 10.1080/17425255.2018.1550485. Epub 2018 Dec 4. Review.

PMID:
30479172
13.

Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

Steffens E, Quintens C, Derdelinckx I, Peetermans WE, Van Eldere J, Spriet I, Schuermans A.

Infection. 2019 Apr;47(2):169-181. doi: 10.1007/s15010-018-1250-1. Epub 2018 Nov 15. Review.

PMID:
30443780
14.

Population pharmacokinetic modelling of intravenous paracetamol in fit older people displays extensive unexplained variability.

Mian P, van Esdonk MJ, Olkkola KT, de Winter BCM, Liukas A, Spriet I, Tibboel D, Petrovic M, Koch BCP, Allegaert K.

Br J Clin Pharmacol. 2019 Jan;85(1):126-135. doi: 10.1111/bcp.13770. Epub 2018 Oct 25.

PMID:
30321459
15.

Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.

Vanderbeke L, Spriet I, Breynaert C, Rijnders BJA, Verweij PE, Wauters J.

Curr Opin Infect Dis. 2018 Dec;31(6):471-480. doi: 10.1097/QCO.0000000000000504.

PMID:
30299367
16.

Dose Reduction May Jeopardize Efficacy of Abiraterone Acetate.

Woei-A-Jin FJSH, Van Nieuwenhuyse T, van Erp NP, Beuselinck B, Stroobants S, Moes DJAR, Osanto S, Spriet I.

J Clin Oncol. 2018 Oct 20;36(30):3062-3064. doi: 10.1200/JCO.2018.79.3182. Epub 2018 Sep 6. No abstract available.

PMID:
30188790
17.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

18.

Medication review versus usual care to improve drug therapies in older inpatients not admitted to geriatric wards: a quasi-experimental study (RASP-IGCT).

Van der Linden L, Hias J, Dreessen L, Milisen K, Flamaing J, Spriet I, Tournoy J.

BMC Geriatr. 2018 Jul 3;18(1):155. doi: 10.1186/s12877-018-0843-y.

19.

Paracetamol in Older People: Towards Evidence-Based Dosing?

Mian P, Allegaert K, Spriet I, Tibboel D, Petrovic M.

Drugs Aging. 2018 Jul;35(7):603-624. doi: 10.1007/s40266-018-0559-x. Review.

20.

Enough Power to Build a Strong Case for Clinical Pharmacy Services?

Van der Linden L, Spriet I, Tournoy J.

JAMA Intern Med. 2018 Jun 1;178(6):864. doi: 10.1001/jamainternmed.2018.1706. No abstract available.

PMID:
29868735
21.

Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium.

Goemaere B, Lagrou K, Spriet I, Hendrickx M, Becker P.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00591-18. doi: 10.1128/AAC.00591-18. Print 2018 Aug.

22.

Factors impacting unbound vancomycin concentrations in neonates and young infants.

Smits A, Pauwels S, Oyaert M, Peersman N, Spriet I, Saegeman V, Allegaert K.

Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1503-1510. doi: 10.1007/s10096-018-3277-8. Epub 2018 May 16.

PMID:
29770901
23.

Reliability of serum creatinine-based formulae estimating renal function in non-critically ill surgery patients: Focus on augmented renal clearance.

Declercq P, Gijsen M, Meijers B, Schetz M, Nijs S, D'Hoore A, Wauters J, Spriet I.

J Clin Pharm Ther. 2018 Oct;43(5):695-706. doi: 10.1111/jcpt.12695. Epub 2018 May 7.

PMID:
29733108
24.

Development of clinical pharmacy in Belgian hospitals through pilot projects funded by the government.

Somers A, Spinewine A, Spriet I, Steurbaut S, Tulkens P, Hecq JD, Willems L, Robays H, Dhoore M, Yaras H, Vanden Bremt I, Haelterman M.

Acta Clin Belg. 2019 Apr;74(2):75-81. doi: 10.1080/17843286.2018.1462877. Epub 2018 Apr 30.

PMID:
29708056
25.

Clinical Pharmacy Services on Geriatric Care Wards: Catch 22 of Implementation and Research.

Van der Linden L, Hias J, Walgraeve K, Flamaing J, Spriet I, Tournoy J.

Drugs Aging. 2018 May;35(5):375-377. doi: 10.1007/s40266-018-0547-1. No abstract available.

PMID:
29671214
26.

Higher versus standard amikacin single dose in emergency department patients with severe sepsis and septic shock: a randomised controlled trial.

De Winter S, Wauters J, Meersseman W, Verhaegen J, Van Wijngaerden E, Peetermans W, Annaert P, Verelst S, Spriet I.

Int J Antimicrob Agents. 2018 Apr;51(4):562-570. doi: 10.1016/j.ijantimicag.2017.11.009. Epub 2017 Nov 24.

PMID:
29180278
27.

Proficiency Testing for Meropenem and Piperacillin Therapeutic Drug Monitoring: Preliminary Results From the Belgian Society on Infectiology and Clinical Microbiology Pharmacokinetic-Pharmacodynamic Working Group.

Carlier M, Athanasopoulos A, Borrey D, Colin P, Cotton F, Denooz R, Neels H, Spriet I, Ghys T, Verstraete AG, Stove V.

Ther Drug Monit. 2018 Feb;40(1):156-158. doi: 10.1097/FTD.0000000000000467. No abstract available.

PMID:
29140892
28.

Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals.

Goemaere B, Becker P, Van Wijngaerden E, Maertens J, Spriet I, Hendrickx M, Lagrou K.

Mycoses. 2018 Feb;61(2):127-133. doi: 10.1111/myc.12714. Epub 2017 Nov 15.

PMID:
29024057
29.

Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.

van Cann T, Loyson T, Verbiest A, Clement PM, Bechter O, Willems L, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Debruyne PR, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinck B.

Support Care Cancer. 2018 Mar;26(3):869-878. doi: 10.1007/s00520-017-3903-5. Epub 2017 Sep 30.

PMID:
28963584
30.

Predictors for unintentional medication reconciliation discrepancies in preadmission medication: a systematic review.

Hias J, Van der Linden L, Spriet I, Vanbrabant P, Willems L, Tournoy J, De Winter S.

Eur J Clin Pharmacol. 2017 Nov;73(11):1355-1377. doi: 10.1007/s00228-017-2308-1. Epub 2017 Jul 25. Review.

PMID:
28744584
31.

Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.

Loyson T, Van Cann T, Schöffski P, Clement PM, Bechter O, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinck B.

Acta Clin Belg. 2018 Apr;73(2):100-109. doi: 10.1080/17843286.2017.1348001. Epub 2017 Jul 10.

PMID:
28693379
32.

Developing a decision rule to optimise clinical pharmacist resources for medication reconciliation in the emergency department.

De Winter S, Vanbrabant P, Laeremans P, Foulon V, Willems L, Verelst S, Spriet I.

Emerg Med J. 2017 Aug;34(8):502-508. doi: 10.1136/emermed-2016-205804. Epub 2017 May 10.

PMID:
28490484
33.

Development of a risk score for QTc-prolongation: the RISQ-PATH study.

Vandael E, Vandenberk B, Vandenberghe J, Spriet I, Willems R, Foulon V.

Int J Clin Pharm. 2017 Apr;39(2):424-432. doi: 10.1007/s11096-017-0446-2. Epub 2017 Mar 9.

PMID:
28281228
34.

Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.

Vanhove T, Bouwsma H, Hilbrands L, Swen JJ, Spriet I, Annaert P, Vanaudenaerde B, Verleden G, Vos R, Kuypers DRJ.

Am J Transplant. 2017 Sep;17(9):2372-2380. doi: 10.1111/ajt.14232. Epub 2017 Apr 8.

35.

AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin.

Flechet M, Güiza F, Schetz M, Wouters P, Vanhorebeek I, Derese I, Gunst J, Spriet I, Casaer M, Van den Berghe G, Meyfroidt G.

Intensive Care Med. 2017 Jun;43(6):764-773. doi: 10.1007/s00134-017-4678-3. Epub 2017 Jan 27.

PMID:
28130688
36.

Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical Outcome.

Van der Linden L, Decoutere L, Walgraeve K, Milisen K, Flamaing J, Spriet I, Tournoy J.

Drugs Aging. 2017 Feb;34(2):123-133. doi: 10.1007/s40266-016-0424-8.

PMID:
27915457
37.

Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients.

Vanhove T, Spriet I, Annaert P, Maertens J, Van Cleemput J, Vos R, Kuypers D.

Ther Drug Monit. 2017 Feb;39(1):77-82. doi: 10.1097/FTD.0000000000000356.

PMID:
27861314
38.

Appropriateness of Acid Suppression Therapy.

De Rijdt T, Spriet I, Willems L, Blanckaert M, Hiele M, Wilmer A, Simoens S.

Ann Pharmacother. 2017 Feb;51(2):125-134. doi: 10.1177/1060028016670414. Epub 2016 Oct 1.

PMID:
27650819
39.

Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates.

Samardzic J, Smits A, Spriet I, Soldatovic I, Atkinson A, Bajcetic M, Van Den Anker JN, Allegaert K.

Biomed Res Int. 2016;2016:1974972. doi: 10.1155/2016/1974972. Epub 2016 Aug 21.

40.

Stability of Drugs Used in Helicopter Air Medical Emergency Services: An Exploratory Study.

De Winter S, Bronselaer K, Vanbrabant P, Blanchaert B, Mansour MF, Brandolisio D, De Jonge S, Slaets P, Sas P, Van Schepdael A, Spriet I.

Air Med J. 2016 Jul-Aug;35(4):247-50. doi: 10.1016/j.amj.2016.02.001. Epub 2016 Apr 16.

PMID:
27393763
41.

Augmented renal clearance in non-critically ill abdominal and trauma surgery patients is an underestimated phenomenon: A point prevalence study.

Declercq P, Nijs S, DʼHoore A, Van Wijngaerden E, Wolthuis A, de Buck van Overstraeten A, Wauters J, Spriet I.

J Trauma Acute Care Surg. 2016 Sep;81(3):468-77. doi: 10.1097/TA.0000000000001138.

PMID:
27257707
42.

Substitution as a Strategy to Improve Excipient Exposure in Neonates: One Piece of the Puzzle.

Allegaert K, Spriet I.

Paediatr Drugs. 2016 Jun;18(3):231-3. doi: 10.1007/s40272-016-0178-0. No abstract available.

PMID:
27146403
43.

Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.

Vanstraelen K, Prattes J, Maertens J, Lagrou K, Schoemans H, Peersman N, Vermeersch P, Theunissen K, Mols R, Augustijns P, Annaert P, Hoenigl M, Spriet I.

Eur J Clin Pharmacol. 2016 Aug;72(8):953-63. doi: 10.1007/s00228-016-2057-6. Epub 2016 Apr 11.

PMID:
27066958
44.

Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.

Vandael E, Vandenberk B, Vandenberghe J, Spriet I, Willems R, Foulon V.

Int J Clin Pharm. 2016 Apr;38(2):310-20. doi: 10.1007/s11096-015-0242-9. Epub 2016 Jan 9.

PMID:
26749342
45.

Exploring the relationship between fall risk-increasing drugs and fall-related fractures.

De Winter S, Vanwynsberghe S, Foulon V, Dejaeger E, Flamaing J, Sermon A, Van der Linden L, Spriet I.

Int J Clin Pharm. 2016 Apr;38(2):243-51. doi: 10.1007/s11096-015-0230-0. Epub 2016 Jan 9.

PMID:
26749341
46.

Plasmalyte: No Longer a Culprit in Causing False-Positive Galactomannan Test Results.

Spriet I, Lagrou K, Maertens J, Willems L, Wilmer A, Wauters J.

J Clin Microbiol. 2016 Mar;54(3):795-7. doi: 10.1128/JCM.02813-15. Epub 2015 Dec 30.

47.

Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?

Prattes J, Raggam RB, Vanstraelen K, Rabensteiner J, Hoegenauer C, Krause R, Prüller F, Wölfler A, Spriet I, Hoenigl M.

J Clin Microbiol. 2016 Mar;54(3):798-801. doi: 10.1128/JCM.02972-15. Epub 2015 Dec 30.

48.

Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area.

Vanstraelen K, Colita A, Bica AM, Mols R, Augustijns P, Peersman N, Vermeersch P, Annaert P, Spriet I.

Pediatr Infect Dis J. 2016 Feb;35(2):183-8. doi: 10.1097/INF.0000000000000963.

PMID:
26544987
49.

Factors impacting unbound vancomycin concentrations in different patient populations.

Oyaert M, Spriet I, Allegaert K, Smits A, Vanstraelen K, Peersman N, Wauters J, Verhaegen J, Vermeersch P, Pauwels S.

Antimicrob Agents Chemother. 2015 Nov;59(11):7073-9. doi: 10.1128/AAC.01185-15. Epub 2015 Sep 8.

50.

Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.

Vanstraelen K, Maertens J, Augustijns P, Lagrou K, de Loor H, Mols R, Annaert P, Malfroot A, Spriet I.

Clin Pharmacokinet. 2015 Nov;54(11):1151-60. doi: 10.1007/s40262-015-0269-z.

PMID:
25910879

Supplemental Content

Loading ...
Support Center